2021 MIPS Quality Benchmarks

What Are Quality Measure Benchmarks?

When a clinician or group submits measures for the Merit-based Incentive Payment System (MIPS) quality performance category, each measure is assessed against its benchmark to determine how many points the measure earns. In program year 2020, a clinician or group can receive anywhere from 3 to 10 points* for each MIPS measure (not including any bonus points) that meets the data completeness standards and case minimum requirements through Benchmarks. Benchmarks are specific to the collection type: Qualified Clinical Data Registry (QCDR) measures, MIPS Clinical Quality Measures (MIPS CQMs)*, eCQMs, CMS Web Interface measures, the Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS survey, and Part B Claims measures. In order to measure performance that is comparable across the spectrum of performance, benchmarks are established using historical data. Historical benchmarks are based on actual performance data from 2018 that was submitted to the Quality Payment Program (QPP) in 2018.  *MIPS CQMs are measures submitted using registry rules.

How Do Benchmarks Work for Multi-Performance Rate Measures?

Several MIPS quality measures require the collection and submission of data for multiple populations. This means that there can be multiple performance rates associated with a single measure. Historical benchmarks for multi-performance rate measures are created based on an "overall performance rate" (based on a weighted average, simple average or CMS-specified performance rate):

How Are Benchmarks Displayed?

Each benchmark is presented in terms of deciles. Points will be awarded within each decile (see table below). Clinicians who receive a score in the first or second decile will receive 3 points. Clinicians who are in the 3rd decile will receive somewhere between 3 and 3.9 points depending on their exact position in the decile, and clinicians in higher deciles will receive a corresponding number of points. For example, if a clinician submits performance data of 83% on a non-inverse measure, and the 5th decile begins at 72% and the 6th decile begins at 85%, then the clinician will receive between 5 and 5.9 points because 83% is in the 5th decile. For inverse measures where a higher performance is seen by a lower number on the performance score, the scores are reversed in the benchmark deciles (example: Measure 1). An Excel version of the 2021 MIPS Quality Historical Benchmarks can be found here

*Measures marked in blue (example: Measure 130) can only earn a maximum score of 7 points.  There are 72 Measures that meet this description.  Topped-out means that the national median performance rate is so high that there is no meaningful difference in performance between clinicians.

Measure NameMeasure IDCollection TypeDecile 3Decile 4Decile 5Decile 6Decile 7Decile 8Decile 9Decile 10
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1MIPS CQM90.69 - 72.5272.51 - 55.1855.17 - 41.9941.98 - 32.5732.56 - 25.4925.48 - 19.1619.15 - 12.88<=12.87
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1eCQM90.50 - 69.4369.42 - 53.6153.6 - 42.1242.11 - 34.0734.06 - 28.3328.32 - 23.5723.56 - 19.11<=19.1
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1Medicare Part B Claims79.99 - 70.0170 - 60.0160 - 50.0150 - 40.0140 - 30.0130 - 20.0120 - 10.01<= 10
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)5eCQM1.09 - 65.5165.52 - 71.9471.95 - 75.2775.28 - 78.0878.09 - 80.4680.47 - 82.9782.98 - 86.35>= 86.36
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)5MIPS CQM90.0 - 95.795.71 - 98.0198.02 - 99.2699.27 - 99.99------100
Coronary Artery Disease (CAD): Antiplatelet Therapy6MIPS CQM77.58 - 82.9782.98 - 86.9786.98 - 90.3490.35 - 93.2693.27 - 95.8695.87 - 98.9398.94 - 99.99100
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)7eCQM45.83 - 71.5671.57 - 83.8783.88 - 88.7488.75 - 91.7891.79 - 94.194.11 - 95.7895.79 - 97.74>= 97.75
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)7MIPS CQM49.07 - 74.0374.04 - 84.7884.79 - 91.9291.93 - 94.7194.72 - 97.7297.73 - 99.99--100
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)8eCQM86.69 - 90.1390.14 - 92.392.31 - 94.0494.05 - 95.2395.24 - 96.3696.37 - 97.4397.44 - 99.99100
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)8MIPS CQM95.0 - 97.4997.5 - 99.1399.14 - 99.99-100   
Anti-Depressant Medication Management9eCQM65.38 - 70.6870.69 - 74.3374.34 - 78.0378.04 - 80.9480.95 - 83.7683.77 - 86.6686.67 - 90.55>= 90.56
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation12eCQM83.62 - 88.7188.72 - 92.392.31 - 95.0595.06 - 96.9696.97 - 98.3298.33 - 99.2899.29 - 99.99100
Age-Related Macular Degeneration (AMD): Dilated Macular Examination14Medicare Part B Claims--------100   
Age-Related Macular Degeneration (AMD): Dilated Macular Examination14MIPS CQM86.18 - 91.7491.75 - 95.0195.02 - 96.9296.93 - 98.5198.52 - 100   
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care19eCQM54.33 - 66.6666.67 - 75.3375.34 - 81.5981.6 - 87.1787.18 - 91.3691.37 - 95.0795.08 - 97.87>= 97.88
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care19MIPS CQM83.62 - 93.5293.53 - 97.8297.83 - 99.9299.93 - 99.99100   
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin21Medicare Part B Claims--------100   
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin21MIPS CQM78.79 - 97.597.51 - 99.99----100   
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)23Medicare Part B Claims--------100   
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)23MIPS CQM95.45 - 99.999.91 - 99.99----100   
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older24Medicare Part B Claims79.31 - 94.2394.24 - 96.0796.08 - 99.99--100   
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older24MIPS CQM14.13 - 36.3536.36 - 78.0678.07 - 82.8782.88 - 87.8787.88 - 93.7493.75 - 99.7999.8 - 99.99100
Screening for Osteoporosis for Women Aged 65-85 Years of Age39Medicare Part B Claims37.13 - 49.5649.57 - 59.359.31 - 66.3766.38 - 76.0276.03 - 87.287.21 - 96.3396.34 - 99.99100
Screening for Osteoporosis for Women Aged 65-85 Years of Age39MIPS CQM13.41 - 28.5828.59 - 39.7939.8 - 51.4851.49 - 61.4661.47 - 70.3470.35 - 79.6779.68 - 90.84>= 90.85
Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery44MIPS CQM94.29 - 96.596.51 - 98.5698.57 - 99.99--100   
Advance Care Plan47Medicare Part B Claims84.39 - 97.4597.46 - 99.6999.7 - 99.99--100   
Advance Care Plan47MIPS CQM20.33 - 43.8343.84 - 64.4364.44 - 79.0179.02 - 89.2389.24 - 95.5995.6 - 98.9498.95 - 99.99100
Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older48MIPS CQM23.56 - 40.0640.07 - 57.3757.38 - 73.7473.75 - 82.3882.39 - 93.0493.05 - 98.5398.54 - 99.99100
Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older50Medicare Part B Claims97.56 - 99.99------100   
Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older50MIPS CQM57.62 - 74.6574.66 - 84.4584.46 - 90.2790.28 - 95.8595.86 - 99.8499.85 - 99.99--100
Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy52MIPS CQM84.62 - 94.9995.0 - 98.2898.29 - 99.6699.67 - 99.99100   
Appropriate Treatment for Children with Upper Respiratory Infection (URI)65eCQM76.15 - 80.7880.79 - 84.3884.39 - 87.0987.1 - 90.190.11 - 92.8592.86 - 95.5795.58 - 99.99100
Appropriate Treatment for Children with Upper Respiratory Infection (URI)65MIPS CQM93.33 - 95.4495.45 - 97.1397.14 - 98.4398.44 - 99.499.41 - 100   
Appropriate Testing for Children with Pharyngitis66eCQM52.34 - 67.1567.16 - 76.0776.08 - 81.7481.75 - 85.5285.53 - 87.8387.84 - 90.6890.69 - 94.45>= 94.46
Appropriate Testing for Children with Pharyngitis66MIPS CQM80.85 - 88.0888.09 - 93.0993.1 - 97.197.11 - 99.99------100
Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow67MIPS CQM96.41 - 99.99------------100
Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry70MIPS CQM64.44 - 98.4598.46 - 99.99----------100
Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections76Medicare Part B Claims99.7 - 99.99------100   
Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections76MIPS CQM97.2 - 99.4299.43 - 99.99----100   
Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use93Medicare Part B Claims93.55 - 96.2996.3 - 98.198.11 - 99.99--100   
Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use93MIPS CQM83.89 - 89.4589.46 - 92.8592.86 - 95.5195.52 - 97.2597.26 - 100   
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients102eCQM----------------
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients102MIPS CQM90.61 - 97.1197.12 - 99.99----100   
Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer104MIPS CQM95.85 - 99.699.61 - 99.99----100   
Adult Major Depressive Disorder (MDD): Suicide Risk Assessment107eCQM2.04 - 4.754.76 - 10.4710.48 - 22.1222.13 - 37.637.61 - 57.2257.23 - 72.4872.49 - 92.61>= 92.62
Preventive Care and Screening: Influenza Immunization110Medicare Part B Claims----------------
Preventive Care and Screening: Influenza Immunization110eCQM----------------
Preventive Care and Screening: Influenza Immunization110MIPS CQM----------------
Pneumococcal Vaccination Status for Older Adults111Medicare Part B Claims68.68 - 76.3176.32 - 82.4682.47 - 87.5687.57 - 93.0893.09 - 97.8997.9 - 99.99--100
Pneumococcal Vaccination Status for Older Adults111eCQM20.44 - 33.7133.72 - 44.6944.7 - 54.8554.86 - 63.2163.22 - 71.0971.1 - 78.7978.8 - 87.92>= 87.93
Pneumococcal Vaccination Status for Older Adults111MIPS CQM35.11 - 51.2851.29 - 61.8961.9 - 69.1569.16 - 74.9975.0 - 79.8979.9 - 85.8285.83 - 94.99>= 95.0
Breast Cancer Screening112Medicare Part B Claims66.67 - 77.0777.08 - 84.8784.88 - 89.6289.63 - 93.4793.48 - 97.3597.36 - 99.0299.03 - 99.99100
Breast Cancer Screening112eCQM24.44 - 37.1337.14 - 46.3146.32 - 54.454.41 - 61.161.11 - 67.2267.23 - 73.9473.95 - 82.01>= 82.02
Breast Cancer Screening112MIPS CQM22.37 - 39.9940.0 - 50.9750.98 - 60.2660.27 - 70.270.21 - 78.178.11 - 85.8485.85 - 97.35>= 97.36
Colorectal Cancer Screening113Medicare Part B Claims----------------
Colorectal Cancer Screening113eCQM15.15 - 27.5127.52 - 38.7338.74 - 49.0449.05 - 58.358.31 - 67.5467.55 - 76.0576.06 - 85.05>= 85.06
Colorectal Cancer Screening113MIPS CQM----------------
Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis116MIPS CQM62.33 - 75.9976.0 - 86.3586.36 - 93.3293.33 - 96.9196.92 - 98.4298.43 - 99.99--100
Diabetes: Eye Exam117Medicare Part B Claims97.83 - 99.99------100   
Diabetes: Eye Exam117eCQM12.0 - 20.5420.55 - 30.6830.69 - 44.8144.82 - 69.3969.4 - 94.1694.17 - 98.4298.43 - 99.92>= 99.93
Diabetes: Eye Exam117MIPS CQM89.93 - 96.6796.68 - 98.8598.86 - 99.6999.7 - 99.99100   
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)118MIPS CQM72.73 - 76.3176.32 - 79.679.61 - 81.8481.85 - 84.9985.0 - 86.8286.83 - 90.4790.48 - 95.99>= 96.0
Diabetes: Medical Attention for Nephropathy119eCQM70.31 - 76.9176.92 - 81.5481.55 - 85.2285.23 - 88.2388.24 - 91.491.41 - 94.7794.78 - 98.54>= 98.55
Diabetes: Medical Attention for Nephropathy119MIPS CQM71.17 - 79.4779.48 - 86.6686.67 - 91.891.81 - 96.2296.23 - 98.6798.68 - 99.99--100
Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological Evaluation126MIPS CQM59.55 - 74.7574.76 - 86.4886.49 - 94.8694.87 - 99.3199.32 - 99.99----100
Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of Footwear127MIPS CQM58.76 - 74.0274.03 - 85.0585.07 - 94.6494.65 - 99.1799.18 - 99.99----100
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128Medicare Part B Claims91.47 - 98.5798.58 - 99.7299.73 - 99.99--100   
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128eCQM23.26 - 27.4127.42 - 32.6432.65 - 40.940.91 - 53.4253.43 - 69.2669.27 - 83.7983.8 - 95.11>= 95.12
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128MIPS CQM32.73 - 51.0551.06 - 70.1670.17 - 84.6884.69 - 93.2793.28 - 98.0598.06 - 99.7599.76 - 99.99100
Documentation of Current Medications in the Medical Record130Medicare Part B Claims99.67 - 99.9399.94 - 99.99----100   
Documentation of Current Medications in the Medical Record130eCQM83.73 - 91.2791.28 - 94.994.91 - 96.9997.0 - 98.398.31 - 100   
Documentation of Current Medications in the Medical Record130MIPS CQM86.71 - 96.3196.32 - 98.9498.95 - 99.6799.68 - 99.999.91 - 100   
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134Medicare Part B Claims95.94 - 99.599.51 - 99.99----100   
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134eCQM----------------
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134MIPS CQM14.76 - 37.4337.44 - 55.9255.93 - 71.7371.74 - 84.6884.69 - 95.5595.56 - 99.2199.22 - 99.99100
Melanoma: Continuity of Care - Recall System137MIPS CQM95.0 - 98.8398.84 - 99.99----------100
Melanoma: Coordination of Care138MIPS CQM75.51 - 92.5892.59 - 98.898.81 - 99.99--100   
Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care141Medicare Part B Claims--------------100
Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care141MIPS CQM32.62 - 60.3160.32 - 82.1382.14 - 93.4793.48 - 98.5498.55 - 99.99----100
Oncology: Medical and Radiation - Pain Intensity Quantified143eCQM67.56 - 85.3185.32 - 91.8891.89 - 95.3395.34 - 97.0697.07 - 97.9597.96 - 98.7998.8 - 99.8>= 99.81
Oncology: Medical and Radiation - Pain Intensity Quantified143MIPS CQM93.65 - 97.6597.66 - 99.299.21 - 99.8399.84 - 99.99100   
Oncology: Medical and Radiation – Plan of Care for Pain144MIPS CQM----------------
Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy145Medicare Part B Claims85.71 - 94.4394.44 - 97.6197.62 - 99.1899.19 - 99.99100   
Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy145MIPS CQM86.61 - 95.4795.48 - 98.498.41 - 99.7299.73 - 99.99100   
Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy147Medicare Part B Claims71.43 - 85.785.71 - 95.4495.45 - 98.4598.46 - 99.99100   
Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy147MIPS CQM93.66 - 98.9198.92 - 99.99----100   
Falls: Risk Assessment154Medicare Part B Claims99.07 - 99.99------100   
Falls: Risk Assessment154MIPS CQM87.86 - 96.1296.13 - 98.8198.82 - 99.99--100   
Falls: Plan of Care155Medicare Part B Claims87.5 - 98.0798.08 - 99.99----100   
Falls: Plan of Care155MIPS CQM85.88 - 93.8793.88 - 97.8397.84 - 99.99--------100
Coronary Artery Bypass Graft (CABG): Prolonged Intubation164MIPS CQM8.8 - 7.77.69 - 5.885.87 - 5.015.0 - 3.533.52 - 2.642.63 - 1.61.59 - 0.010
Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure167MIPS CQM3.6 - 2.452.44 - 2.052.04 - 1.481.47 - 1.231.22 - 0.560.55 - 0.01--0
Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration168MIPS CQM3.04 - 2.492.48 - 2.152.14 - 1.561.55 - 1.221.21 - 0.490.48 - 0.01--0
Rheumatoid Arthritis (RA): Tuberculosis Screening176MIPS CQM51.61 - 77.6277.63 - 89.789.71 - 93.1993.2 - 97.3697.37 - 99.99----100
Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity177MIPS CQM65.49 - 75.1975.2 - 85.3785.38 - 91.0391.04 - 95.2195.22 - 98.2298.23 - 99.6699.67 - 99.99100
Rheumatoid Arthritis (RA): Functional Status Assessment178MIPS CQM76.28 - 89.3989.4 - 94.2594.26 - 97.7197.72 - 99.0299.03 - 100   
Rheumatoid Arthritis (RA): Glucocorticoid Management180MIPS CQM98.26 - 99.6899.69 - 99.99----------100
Elder Maltreatment Screen and Follow-Up Plan181Medicare Part B Claims98.88 - 99.99------100   
Elder Maltreatment Screen and Follow-Up Plan181MIPS CQM58.52 - 78.6578.66 - 89.1289.13 - 95.6595.66 - 98.9198.92 - 99.99----100
Functional Outcome Assessment182Medicare Part B Claims99.56 - 99.99------100   
Functional Outcome Assessment182MIPS CQM98.57 - 99.5899.59 - 99.8399.84 - 99.99--------100
Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate Use185MIPS CQM44.62 - 81.2481.25 - 90.5890.59 - 95.7395.74 - 98.0498.05 - 99.5499.55 - 99.99--100
Stroke and Stroke Rehabilitation: Thrombolytic Therapy187MIPS CQM82.74 - 88.3188.32 - 91.6691.67 - 93.5493.55 - 95.4495.45-100   
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery191eCQM88.04 - 93.4593.46 - 95.795.71 - 97.1297.13 - 98.2298.23 - 98.8598.86 - 99.4999.5 - 99.99100
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery191MIPS CQM94.17 - 96.2996.3 - 97.4397.44 - 98.4498.45 - 99.4499.45 - 99.99----100
Radiology: Stenosis Measurement in Carotid Imaging Reports195Medicare Part B Claims97.77 - 99.3999.4 - 99.99----100   
Radiology: Stenosis Measurement in Carotid Imaging Reports195MIPS CQM99.28 - 99.8399.84 - 99.99----100   
HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis205MIPS CQM----------------
Functional Status Change for Patients with Knee Impairments217MIPS CQM----------------
Functional Status Change for Patients with Hip Impairments218MIPS CQM----------------
Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments219MIPS CQM----------------
Functional Status Change for Patients with Low Back Impairments220MIPS CQM----------------
Functional Status Change for Patients with Shoulder Impairments221MIPS CQM----------------
Functional Status Change for Patients with Elbow, Wrist or Hand Impairments222MIPS CQM----------------
Radiology: Reminder System for Screening Mammograms225Medicare Part B Claims--------------100
Radiology: Reminder System for Screening Mammograms225MIPS CQM--------------100
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226Medicare Part B Claims----------------
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226eCQM----------------
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226MIPS CQM----------------
Controlling High Blood Pressure236Medicare Part B Claims20 - 29.9930 - 39.9940 - 49.9950 - 59.9960 - 69.9970 - 79.9980 - 89.99>= 90
Controlling High Blood Pressure236MIPS CQM20 - 29.9930 - 39.9940 - 49.9950 - 59.9960 - 69.9970 - 79.9980 - 89.99>= 90
Controlling High Blood Pressure236eCQM51.69 - 57.0757.08 - 61.3261.33 - 64.7964.8 - 68.4468.45 - 72.0372.04 - 76.3576.36 - 82.37>= 82.38
Use of High-Risk Medications in the Elderly238MIPS CQM----------------
Use of High-Risk Medications in the Elderly238eCQM----------------
Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents239eCQM27.47 - 30.4830.49 - 32.1232.13 - 33.3233.33 - 34.4734.48 - 38.5338.54 - 47.9247.93 - 63.64>= 63.65
Childhood Immunization Status240eCQM17.93 - 25.5325.54 - 32.3932.4 - 36.7436.75 - 40.1840.19 - 44.7344.74 - 49.5649.57 - 56.85>= 56.86
Cardiac Rehabilitation Patient Referral from an Outpatient Setting243MIPS CQM19.02 - 25.6325.64 - 31.4231.43 - 37.1337.14 - 42.8542.86 - 48.9748.98 - 63.763.71 - 90.57>= 90.58
Barrett's Esophagus249Medicare Part B Claims--------100   
Barrett's Esophagus249MIPS CQM--------100   
Radical Prostatectomy Pathology Reporting250Medicare Part B Claims--------100   
Radical Prostatectomy Pathology Reporting250MIPS CQM--------100   
Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain254Medicare Part B Claims----------------
Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain254MIPS CQM88.64 - 92.2492.25 - 95.2595.26 - 96.7696.77 - 98.2498.25-100   
Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7)258MIPS CQM----------------
Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative Day #2)259MIPS CQM----------------
Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)260MIPS CQM----------------
Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness261Medicare Part B Claims----------------
Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness261MIPS CQM----------------
Sentinel Lymph Node Biopsy for Invasive Breast Cancer264MIPS CQM----------------
Biopsy Follow-Up265MIPS CQM78.39 - 95.495.41 - 99.0799.08 - 99.99--100   
Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy268MIPS CQM14.49 - 23.9924.0 - 39.2139.22 - 49.9950.0 - 65.4765.48 - 89.4989.5 - 94.9995.0 - 99.99100
Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy275MIPS CQM----------------
Sleep Apnea: Severity Assessment at Initial Diagnosis277MIPS CQM24.0 - 42.7942.8 - 58.2258.23 - 71.6471.65 - 93.0993.1 - 99.8699.87 - 99.99--100
Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy279MIPS CQM88.15 - 95.6495.65 - 98.6898.69 - 99.99--100   
Dementia: Cognitive Assessment281eCQM8.33 - 13.6313.64 - 21.7321.74 - 31.5731.58 - 44.8244.83 - 59.7359.74 - 73.973.91 - 91.88>= 91.89
Dementia: Functional Status Assessment282MIPS CQM43.54 - 68.1768.18 - 91.0391.04 - 98.2398.24 - 99.99------100
Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management283MIPS CQM75.0 - 92.4492.45 - 96.3696.37 - 98.6798.68 - 99.99100   
Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia286MIPS CQM86.36 - 93.3793.38 - 97.6697.67 - 99.99--100   
Dementia: Education and Support of Caregivers for Patients with Dementia288MIPS CQM43.28 - 66.6666.67 - 83.3283.33 - 95.3895.39 - 98.3298.33 - 99.99----100
Parkinson's Disease: Psychiatric Symptoms Assessment for Patients with Parkinson's Disease290MIPS CQM34.39 - 57.4657.47 - 81.0781.08 - 92.0592.06 - 98.0598.06 - 99.99----100
Parkinson's Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson's Disease291MIPS CQM25.57 - 59.8859.89 - 89.2789.28 - 98.9398.94 - 99.99100   
Parkinson's Disease: Rehabilitative Therapy Options293MIPS CQM48.35 - 65.765.71 - 85.785.71 - 93.7293.73 - 99.99100   
Cataracts: Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery303MIPS CQM----------------
Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery304MIPS CQM----------------
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment305eCQM0.27 - 0.420.43 - 0.630.64 - 0.910.92 - 1.241.25 - 1.841.85 - 2.92.91 - 7.64>= 7.65
Cervical Cancer Screening309eCQM11.36 - 18.3618.37 - 24.9925.0 - 32.2832.29 - 39.5639.57 - 46.846.81 - 55.5555.56 - 68.16>= 68.17
Chlamydia Screening for Women310eCQM19.88 - 26.6626.67 - 32.1932.2 - 37.6537.66 - 42.4642.47 - 47.4947.5 - 56.0656.07 - 65.96>= 65.97
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317Medicare Part B Claims----------------
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317eCQM----------------
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317MIPS CQM----------------
Falls: Screening for Future Fall Risk318eCQM18.81 - 36.2736.28 - 52.3352.34 - 66.6466.65 - 78.7178.72 - 87.4987.5 - 94.1894.19 - 98.26>= 98.27
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients320Medicare Part B Claims92.68 - 99.0699.07 - 99.99----100   
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients320MIPS CQM81.69 - 89.0189.02 - 93.2993.3 - 95.895.81 - 97.4697.47 - 100   
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients322MIPS CQM0.33 - 0.01------------0
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI)323MIPS CQM--------------0
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients324MIPS CQM2.51 - 0.720.71 - 0.01----------0
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy326Medicare Part B Claims98.63 - 99.99------100   
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy326MIPS CQM79.1 - 83.6783.68 - 88.4588.46 - 94.594.51 - 98.798.71 - 100   
Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)331MIPS CQM75.95 - 62.5162.5 - 50.1350.12 - 37.5837.57 - 25.1325.12 - 14.8214.81 - 5.295.28 - 0.010
Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)332MIPS CQM52.44 - 61.3661.37 - 72.6372.64 - 85.7585.76 - 89.9389.94 - 96.1296.13 - 99.99--100
Maternity Care: Elective Delivery or Early Induction Without Medical Indication at < 39 Weeks (Overuse)335MIPS CQM----------------
Maternity Care: Postpartum Follow-up and Care Coordination336MIPS CQM----------------
Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier337MIPS CQM68.0 - 80.7680.77 - 88.8888.89 - 94.4194.42 - 97.5397.54 - 99.99----100
HIV Viral Load Suppression338MIPS CQM76.89 - 84.284.21 - 87.3287.33 - 91.5491.55 - 95.3695.37 - 96.9696.97 - 99.99--100
HIV Medical Visit Frequency340MIPS CQM54.8 - 60.0860.09 - 69.9970.0 - 74.9975.0 - 84.584.51 - 98.4798.48 - 99.99--100
Pain Brought Under Control Within 48 Hours342MIPS CQM--------------100
Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)344MIPS CQM----------------
Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy350MIPS CQM99.6 - 99.99------100   
Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation351MIPS CQM99.36 - 99.99------100   
Anastomotic Leak Intervention354MIPS CQM3.23 - 1.81.79 - 0.01----------0
Unplanned Reoperation within the 30 Day Postoperative Period355MIPS CQM2.45 - 1.341.33 - 0.80.79 - 0.190.18 - 0.01------0
Unplanned Hospital Readmission within 30 Days of Principal Procedure356MIPS CQM5.76 - 3.963.95 - 2.792.78 - 1.11.09 - 0.01------0
Surgical Site Infection (SSI)357MIPS CQM3.33 - 1.831.82 - 0.780.77 - 0.01--------0
Patient-Centered Surgical Risk Assessment and Communication358MIPS CQM34.62 - 72.4272.43 - 91.2291.23 - 98.598.51 - 99.99------100
Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies360MIPS CQM85.51 - 98.7698.77 - 99.9399.94 - 99.99--100   
Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines364MIPS CQM95.83 - 98.198.11 - 99.99----------100
Follow-Up Care for Children Prescribed ADHD Medication (ADD)366eCQM20.31 - 24.1324.14 - 29.5429.55 - 35.9435.95 - 39.5239.53 - 45.4845.49 - 50.5850.59 - 65.63>= 65.64
Depression Remission at Twelve Months370MIPS CQM----------------
Depression Remission at Twelve Months370eCQM3.65 - 4.914.92 - 6.336.34 - 7.67.61 - 9.629.63 - 11.9912.0 - 14.9915 - 22.02>= 22.03
Closing the Referral Loop: Receipt of Specialist Report374eCQM9.72 - 16.9716.98 - 25.525.51 - 34.9234.93 - 46.4246.43 - 59.9960.0 - 74.5974.6 - 89.65>= 89.66
Closing the Referral Loop: Receipt of Specialist Report374MIPS CQM60.0 - 77.5477.55 - 92.392.31 - 97.5497.55 - 99.99------100
Functional Status Assessment for Total Knee Replacement375eCQM8.19 - 10.3110.32 - 14.8314.84 - 21.0921.1 - 29.0829.09 - 37.4937.5 - 51.3451.35 - 61.02>= 61.03
Functional Status Assessment for Total Hip Replacement376eCQM4.73 - 8.328.33 - 11.5311.54 - 15.8215.83 - 19.7419.75 - 33.3233.33 - 53.5653.57 - 99.99100
Functional Status Assessments for Congestive Heart Failure377eCQM----------------
Children Who Have Dental Decay or Cavities378eCQM0.87 - 0.390.38 - 0.01----------0
Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists379eCQM0.26 - 0.530.54 - 1.091.1 - 2.182.19 - 3.843.85 - 5.225.23 - 7.37.31 - 13.66>= 13.67
Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment382eCQM7.45 - 12.4912.5 - 19.1119.12 - 29.7929.8 - 39.0839.09 - 47.147.11 - 58.758.71 - 87.46>= 87.47
Adherence to Antipsychotic Medications For Individuals with Schizophrenia383MIPS CQM51.52 - 80.8480.85 - 96.5196.52 - 99.99--------100
Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery384MIPS CQM96.0 - 99.99------------100
Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery385MIPS CQM----------------
Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences386MIPS CQM----------------
Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users387MIPS CQM----------------
Cataract Surgery: Difference Between Planned and Final Refraction389MIPS CQM30.48 - 38.5338.54 - 51.9451.95 - 71.0771.08 - 94.4594.46 - 98.1898.19 - 99.99--100
Follow-Up After Hospitalization for Mental Illness (FUH)391MIPS CQM----------------
Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation392MIPS CQM----------------
Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision393MIPS CQM----------------
Immunizations for Adolescents394MIPS CQM3.28 - 7.687.69 - 18.5818.59 - 22.7222.73 - 23.9623.97 - 30.4230.43 - 38.7238.73 - 46.66>= 46.67
Lung Cancer Reporting (Biopsy/Cytology Specimens)395Medicare Part B Claims--------100   
Lung Cancer Reporting (Biopsy/Cytology Specimens)395MIPS CQM--------100   
Lung Cancer Reporting (Resection Specimens)396Medicare Part B Claims--------100   
Lung Cancer Reporting (Resection Specimens)396MIPS CQM--------100   
Melanoma Reporting397Medicare Part B Claims--------100   
Melanoma Reporting397MIPS CQM--------100   
Optimal Asthma Control398MIPS CQM33.33 - 49.2849.29 - 58.0458.05 - 80.1380.14 - 99.99------100
One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk400MIPS CQM1.39 - 2.022.03 - 3.933.94 - 9.289.29 - 18.0218.03 - 28.7728.78 - 43.8143.82 - 75.52>= 75.53
Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis401MIPS CQM----------------
Tobacco Use and Help with Quitting Among Adolescents402MIPS CQM88.14 - 93.5493.55 - 96.5496.55 - 98.4598.46 - 99.5599.56-100   
Anesthesiology Smoking Abstinence404MIPS CQM53.27 - 62.1962.2 - 68.1768.18 - 73.1773.18 - 79.1879.19 - 84.4284.43 - 91.7591.76 - 98.2>= 98.21
Appropriate Follow-up Imaging for Incidental Abdominal Lesions405Medicare Part B Claims----------------
Appropriate Follow-up Imaging for Incidental Abdominal Lesions405MIPS CQM----------------
Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients406Medicare Part B Claims0.4 - 0.01------0   
Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients406MIPS CQM2.27 - 0.01------0   
Clinical Outcome Post Endovascular Stroke Treatment409MIPS CQM----------------
Psoriasis: Clinical Response to Systemic Medications410MIPS CQM56.12 - 70.5870.59 - 79.9980.0 - 87.8787.88 - 93.3293.33 - 97.4397.44 - 99.99--100
Door to Puncture Time for Endovascular Stroke Treatment413MIPS CQM----------------
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older415MIPS CQM83.73 - 90.990.91 - 94.4394.44 - 96.3996.4 - 97.5597.56 - 98.5498.55 - 99.4199.42 - 99.99100
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years416MIPS CQM27.21 - 20.0120.0 - 12.1312.12 - 5.895.88 - 3.463.45 - 2.052.04 - 0.01--0
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years416Medicare Part B Claims----------------
Osteoporosis Management in Women Who Had a Fracture418Medicare Part B Claims----------------
Osteoporosis Management in Women Who Had a Fracture418MIPS CQM----------------
Overuse of Imaging for the Evaluation of Primary Headache419MIPS CQM28.52 - 16.3616.35 - 10.4410.43 - 5.365.35 - 3.243.23 - 1.631.62 - 0.210.2 - 0.010
Varicose Vein Treatment with Saphenous Ablation: Outcome Survey420MIPS CQM----------------
Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal421MIPS CQM----------------
Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury422MIPS CQM----------------
Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury422Medicare Part B Claims----------------
Perioperative Temperature Management424MIPS CQM98.22 - 99.2699.27 - 99.6899.69 - 99.8599.86 - 99.9699.97 - 99.99----100
Photodocumentation of Cecal Intubation425Medicare Part B Claims98.8 - 99.4399.44 - 99.99----------100
Photodocumentation of Cecal Intubation425MIPS CQM89.1 - 94.7794.78 - 96.7296.73 - 97.9597.96 - 98.5598.56 - 99.1299.13 - 99.4799.48 - 99.94>= 99.95
Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy429Medicare Part B Claims----------------
Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy429MIPS CQM----------------
Prevention of Post-Operative Nausea and Vomiting (PONV) - Combination Therapy430MIPS CQM96.68 - 98.1798.18 - 98.9398.94 - 99.4999.5 - 99.7799.78-100   
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling431MIPS CQM----------------
Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair432MIPS CQM----------------
Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair433MIPS CQM----------------
Proportion of Patients Sustaining a Ureter Injury at the Time of Pelvic Organ Prolapse Repair434MIPS CQM----------------
Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques436Medicare Part B Claims96.5 - 98.6798.68 - 99.5699.57 - 99.8799.88 - 99.99100   
Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques436MIPS CQM98.96 - 99.7699.77 - 99.9699.97 - 99.99--100   
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease438eCQM62.47 - 66.2166.22 - 68.9668.97 - 71.3671.37 - 73.7473.75 - 76.0776.08 - 79.5679.57 - 83.32>= 83.33
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease438MIPS CQM67.31 - 73.0273.03 - 76.4976.5 - 82.3982.4 - 87.4387.44 - 93.0993.1 - 99.99--100
Age Appropriate Screening Colonoscopy439MIPS CQM----------------
Skin Cancer: Biopsy Reporting Time - Pathologist to Clinician440MIPS CQM98.36 - 99.7199.72 - 99.99----100   
Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)441MIPS CQM12.76 - 22.3222.33 - 27.5527.56 - 36.4436.45 - 42.5442.55 - 48.4748.48 - 55.5555.56 - 63.96>= 63.97
Non-Recommended Cervical Cancer Screening in Adolescent Females443MIPS CQM----------------
Medication Management for People with Asthma444MIPS CQM----------------
Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)445MIPS CQM4.0 - 2.982.97 - 2.412.4 - 1.951.94 - 1.051.04 - 0.680.67 - 0.01--0
Appropriate Workup Prior to Endometrial Ablation448MIPS CQM----------------
Trastuzumab Received By Patients With AJCC Stage I (T1c) - III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy450MIPS CQM----------------
RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy451MIPS CQM----------------
Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies452MIPS CQM----------------
Percentage of Patients Who Died from Cancer Receiving Chemotherapy in the Last 14 Days of Life (lower score - better)453MIPS CQM18.18 - 15.5715.56 - 13.9613.95 - 11.2811.27 - 10.0110.0 - 8.588.57 - 6.076.06 - 0.010
Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score - better)455MIPS CQM----------------
Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score - better)457MIPS CQM11.32 - 10.0110.0 - 8.178.16 - 6.996.98 - 4.274.26 - 3.043.03 - 2.232.22 - 0.010
Back Pain After Lumbar Discectomy/Laminectomy459MIPS CQM----------------
Back Pain After Lumbar Fusion460MIPS CQM----------------
Leg Pain After Lumbar Discectomy/Laminectomy461MIPS CQM----------------
Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy462eCQM----------------
Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics)463MIPS CQM94.59 - 97.2997.3 - 98.2498.25 - 99.0799.08 - 99.6699.67 - 100   
Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use464MIPS CQM84.47 - 87.5287.53 - 89.9990.0 - 92.7492.75 - 94.5394.54 - 96.1496.15 - 97.5997.6 - 99.99100
Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries465MIPS CQM----------------
Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)468MIPS CQM----------------
Functional Status After Lumbar Fusion469MIPS CQM----------------
Functional Status After Primary Total Knee Replacement470MIPS CQM----------------
Functional Status After Lumbar Discectomy/Laminectomy471MIPS CQM----------------
Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture472eCQM--------------0
Leg Pain After Lumbar Fusion473MIPS CQM----------------
HIV Screening475eCQM1.46 - 2.442.45 - 5.315.32 - 9.489.49 - 25.525.51 - 99.99----100
International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia476eCQM----------------
Multimodal Pain Management477MIPS CQM----------------
Functional Status Change for Patients with Neck Impairments478MIPS CQM----------------

Register with MDinteractive